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Abstract
Introduction Electrolyte disorders are an important cause of ventricular and supraventricular arrhythmias as well as various
other complications in the intensive care unit. Patients undergoing cardiac surgery are at risk for development of
tachyarrhythmias, especially in the period during and immediately after surgical intervention. Preventing electrolyte disorders
is thus an important goal of therapy in such patients. However, although levels of potassium are usually measured regularly in
these patients, other electrolytes such as magnesium, phosphate and calcium are measured far less frequently. We
hypothesized that patients undergoing cardiac surgical procedures might be at risk for electrolyte depletion, and we therefore
conducted the present study to assess electrolyte levels in such patients.
Methods Levels of magnesium, phosphate, potassium, calcium and sodium were measured in 500 consecutive patients
undergoing various cardiac surgical procedures who required extracorporeal circulation (group 1). A total of 250 patients
admitted to the intensive care unit following other major surgical procedures served as control individuals (group 2). Urine
electrolyte excretion was measured in a subgroup of 50 patients in both groups.
Results All cardiac patients received 1 l cardioplegia solution containing 16 mmol potassium and 16 mmol magnesium. In
addition, intravenous potassium supplementation was greater in cardiac surgery patients (mean ± standard error: 10.2 ± 4.8
mmol/hour in cardiac surgery patients versus 1.3 ± 1.0 in control individuals; P < 0.01), and most (76% versus 2%; P < 0.01)
received one or more doses of magnesium (on average 2.1 g) for clinical reasons, mostly intraoperative arrhythmia. Despite
these differences in supplementation, electrolyte levels decreased significantly in cardiac surgery patients, most of whom
(88% of cardiac surgery patients versus 20% of control individuals; P < 0.001) met criteria for clinical deficiency in one or
more electrolytes. Electrolyte levels were as follows (mmol/l [mean ± standard error]; cardiac patients versus control
individuals): phosphate 0.43 ± 0.22 versus 0.92 ± 0.32 (P < 0.001); magnesium 0.62 ± 0.24 versus 0.95 ± 0.27 (P <
0.001); calcium 1.96 ± 0.41 versus 2.12 ± 0.33 (P < 0.001); and potassium 3.6 ± 0.70 versus 3.9 ± 0.63 (P < 0.01).
Magnesium levels in patients who had not received supplementation were 0.47 ± 0.16 mmol/l in group 1 and 0.95 ± 0.26
mmol/l in group 2 (P < 0.001). Urinary excretion of potassium, magnesium and phosphate was high in group 1 (data not
shown), but this alone could not completely account for the observed electrolyte depletion.
Conclusion Patients undergoing cardiac surgery with extracorporeal circulation are at high risk for electrolyte depletion,
despite supplementation of some electrolytes, such as potassium. The probable mechanism is a combination of increased
urinary excretion and intracellular shift induced by a combination of extracorporeal circulation and decreased body
temperature during surgery (hypothermia induced diuresis). Our findings may partly explain the high risk of tachyarrhythmia in
patients who have undergone cardiac surgery. Prophylactic supplementation of potassium, magnesium and phosphate should
be seriously considered in all patients undergoing cardiac surgical procedures, both during surgery and in the immediate
postoperative period. Levels of these electrolytes should be monitored frequently in such patients.
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Introduction
Electrolytes such as potassium, magnesium, calcium and
phosphate play important roles in cellular metabolism and
energy transformation, and in the regulation of cellular mem-
brane potentials, especially those of muscle and nerve cells.
Depletion of these electrolytes can induce a wide range of
clinical disorders, including neuromuscular dysfunction and
severe arrhythmias. The risk for these disorders increases sig-
nificantly when more than one electrolyte is deficient, and
increases still further in the presence of ischaemic heart dis-
ease [1].
It is well known that hypokalaemia can induce cardiac arrhyth-
mias (especially in patients with ischaemic heart disease and
left ventricular hypertrophy), and that it is associated with other
adverse effects such as muscle weakness, rhabdomyolysis,
renal failure and hyperglycaemia. Thus, the importance of reg-
ulating potassium levels is well recognized in most intensive
care units (ICUs) and potassium levels are measured fre-
quently, especially in patients with cardiovascular disease. In
contrast, electrolytes such as magnesium, calcium and phos-
phate are measured far less frequently. However, a large
number of clinical and in vitro studies have provided strong
evidence that depletion of magnesium, phosphate and cal-
cium can adversely affect outcome, especially in patients with
cardiovascular disease. Several studies have been published
that link hypomagnesaemia to increased mortality in the ICU
[2,3] and in the general ward [3]. Hypomagnesaemia is also
associated with adverse outcomes in patients with unstable
angina or myocardial infarction [4-7], and administering mag-
nesium has been shown to reduce mortality and infarction size
in these patients [8-11]. Hypomagnesaemia can cause car-
diac arrhythmias, neuromuscular irritability, hypertension and
vasoconstriction (including constriction of coronary arteries),
as well as metabolic effects including decreased insulin sensi-
tivity [12,13], all of which are extremely undesirable, especially
in patients who have undergone cardiac surgery. In addition,
magnesium appears to play a role in the scavenging of free
radicals and in the prevention of reperfusion injury [14,15].
Because reperfusion injury is thought to play a key role in the
development of myocardial injury during and after coronary
bypass surgery [16-18], the occurrence of hypomagnesaemia
may contribute to this complication.
Low levels of other electrolytes such as phosphate and cal-
cium can also have highly undesirable effects in patients with
cardiovascular disease. Low phosphate levels can affect
numerous intracellular enzymes and energy metabolism, lead-
ing to low levels of intracellular ATP [19]. Clinical symptoms
include muscle weakness, respiratory failure, increased risk for
respiratory infections, impaired myocardial function and a
decrease in cardiac output [13,20-24]. Hypophosphataemia
can lead to ventricular tachycardia in patients with recent myo-
cardial infarction [25]. Low serum calcium levels can also
induce arrhythmias (specifically shortening of the electrocardi-
ographic QT interval). Hypocalcaemia can lead to severe car-
diovascular depression [26,27] and congestive heart failure
that is unresponsive to inotropic agents, especially in patients
with underlying cardiomyopathies [28,29]. These cardiovas-
cular effects may occur in the absence of specific electrocar-
diographic changes. Thus, low electrolyte levels can have
severe adverse effects on the clinical course of patients with
cardiovascular disease. Moreover, when more than one elec-
trolyte is deficient the effects may be cumulative, especially in
the case of magnesium and potassium deficiencies. These
impacts of electrolyte disorders may be more pronounced in
patients undergoing cardiac surgery, who are already at
increased risk for tachyarrhythmia and other haemodynamic
complications during the perioperative and postoperative peri-
ods [1,30,31]. Preventing electrolyte disorders is thus an
important goal of therapy in this category of patients.
During surgery, patients undergoing cardiac surgery are usu-
ally cooled to temperatures between 32°C and 34°C, in order
to reduce tissue oxygen demand. At the end of the procedure
patients are rewarmed to 36°C. We previously reported that
induction of similar degrees of hypothermia induced electro-
lyte loss in patients with severe head injury [32]. Although
hypothermia was maintained much longer in this category of
patients, electrolyte disorders occurred mainly during the
phase when body temperature decreased. This led us to
hypothesize that other groups of patients treated with moder-
ate hypothermia (such as patients undergoing major surgical
interventions) might also be at risk for electrolyte depletion
during the perioperative and postoperative periods. We there-
fore conducted the present study to assess the incidence of
electrolyte depletion in patients who have undergone cardiac
surgery.
Methods
We measured serum levels of magnesium, phosphate, potas-
sium, calcium and sodium at ICU admission in 500 consecu-
tive patients undergoing cardiac surgical interventions (group
1).
The normal reference values for these electrolytes in our labo-
ratory were as follows (all in mmol/l): magnesium 0.8–1.1,
phosphate 0.7–1.2, potassium 3.8–4.8, calcium 2.20–2.60
and sodium 135–145. We used slightly lower levels as cutoff
points for clinically significant electrolyte depletion. These val-
ues were as follows (all in mmol/l): magnesium 0.7, phosphate
0.6, potassium 3.6, calcium 2.0 and sodium 129. We also
measured levels of ionized magnesium and ionized calcium in
a subgroup of 40 patients in each group in order to determine
whether the total serum levels of these electrolytes corre-
sponded with levels of the ionized (i.e. active) form.
Surgical procedures included coronary bypass graft (n  =
352), valve replacement (n = 54), combinations of these (n =
68) and Bentall procedure for dissection of the ascendingAvailable online http://ccforum.com/content/8/6/R459
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aorta (usually in combination with aortic valve replacement; n
= 26). Extracorporeal circulation was employed in all patients
in group 1. Cardioplegic arrest was accomplished using cold
crystalloid solution (average amount 1000 ml). The cardiople-
gic solution contained the following concentrations of electro-
lytes (all mmol/l): sodium 120, potassium 16, magnesium 16,
calcium 1.2 and chlorine 172.
A total of 250 patients who had undergone other major elec-
tive surgical procedures (noncardiac thoracic surgery [i.e. lung
surgery] and repair of abdominal aortic aneurysms) served as
control individuals (group 2). Neurosurgical patients were not
included in the control group because we previously observed
that such patients are at risk for developing low electrolyte lev-
els for various reasons [32-34]. Patients undergoing nonelec-
tive (emergency) surgical procedures were not included in the
present study.
Patients in group 1 were treated with low doses of dopamine
(between 2 and 4 mg/hour; average dose 2.4 mg/hour) and
nitroglycerine (0.1 mg/hour), according to protocol. Upon
admission, a fluid infusion containing MgSO4 and phosphate
was initiated in all patients in group 1 after blood sample aspi-
ration. Potassium administration was initiated in all group 1
patients during surgery; this was continued and, in most
patients, increased at ICU admission. Urine production was
measured in all patients. Urinary electrolyte excretion was
measured in 50 patients in each group. Measurements in urine
produced during surgery were obtained (because extra elec-
trolyte administration was initiated soon after ICU admission,
which might have affected urinary excretion).
Where applicable, values are expressed as mean ± standard
error.
Results
The results are summarized in Tables 1 and 2. Electrolyte lev-
els (measured 1–4 days before surgery) were normal before
surgical intervention. Severe electrolyte depletion was
observed in group 1 (cardiac surgery patients). The differ-
ences between group 1 and group 2 (control individuals) were
significant for potassium (P < 0.001), magnesium (P < 0.001),
phosphate (P < 0.001) and calcium (P < 0.001; Table 1).
Potassium levels were significantly lower in group 1 despite
considerable potassium supplementation (10.4 ± 4.6 mmol/
hour in group 1 versus 1.6 ± 1.4 mmol/hour in group 2; P <
0.001). Similarly, magnesium levels were significantly lower
despite the fact that 380 patients in group 1 received magne-
sium during surgery (average amount: 2.1 g) because of
arrhythmias (as compared with only five patients in group 2; P
< 0.001). Calcium was given to 84 patients in group 1 and two
patients in group 2 (P < 0.001) for clinical reasons, mostly
hypotension, prevention or treatment of arrhythmias, and pre-
vention or treatment of excessive blood loss.
Levels of ionized magnesium and ionized calcium were meas-
ured in a subgroup of 40 patients in each group; these levels
corresponded with the corrected levels of non-ionized electro-
lyte levels in these patients. Average levels of ionized magne-
sium were 0.27 ± 0.23 mmol/l in group 1 and 0.48 ± 0.36
mmol/l in group 2 (P < 0.01). Average levels of ionized calcium
were 0.91 ± 0.55 mmol/l and 0.98 ± 0.54 mmol/l in groups 1
and 2, respectively (P < 0.05).
Table 1
Patient data
Parameter Group 1 Group 2 P
Number of patients 500 250
Age (years) 59.9 ± 23.2 60.3 ± 28.6 NS
ICU mortality 5.8% 4.0% P < 0.01
Preoperative serum creatinine levels (µmol/l) 89 (range 53–131) 104 (range 64–153) P < 0.01
Patients treated with dopamine 100% 15% (n = 37) P < 0.001
Average dose of dopamine 5.7 µg/kg per min 6.9 µg/kg per min P < 0.02
Patients treated with furosemide during surgery and/or in the 12-
hour period preceding surgery
35% (n = 176) 25% (n = 63) P < 0.01
Average dose of furosemide 16.7 mg 17.2 mg NS
Rectal temperature at ICU admission 34.6°C 36.0°C P < 0.001
Patients requiring antiarrhythmic medication (amiodarone, sotalol 
or other β blocker)a
189 (38%) 26 (10%) P < 0.001
aPrescribed in the intensive care unit (ICU) for treatment of arrhythmias. Patients using antiarrhythmic medication before surgery not included; 
prescription of β blocker for hypertension not included. Where applicable, values are expressed as mean ± standard error. NS, not significant.Critical Care    December 2004  Vol 8 No 6    Polderman and Girbes 
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Urinary electrolyte excretion, measured in 40 patients in each
group, was as follows (group 1 versus group 2; values
expressed in mmol/hour): magnesium 0.6 ± 0.33 versus 0.20
± 0.32 (P < 0.01); phosphate 5.1 ± 3.0 versus 2.2 ± 2.0 (P <
0.01); potassium 11.0 ± 4.8 versus 7.2 ± 4.8 (P < 0.01); and
calcium 1.2 ± 0.7 versus 0.4 ± 0.2 (P < 0.01).
Significant differences were also observed in the number of
patients with clinically significant electrolyte depletion (i.e. lev-
els below which deleterious effects are likely to occur). In
group 1, 228 patients (44%) had magnesium levels below
0.70 mmol/l, as compared with 40 patients (16%) in group 2
(P < 0.001). As stated above, many patients in group 1 had
been given magnesium during the surgical procedure for clin-
ical reasons (mostly occurrence of brief ventricular or
supraventricular arrhythmias). Of the 120 patients who had
not been given magnesium, 96 (80%) had magnesium levels
below 0.70 mmol/l.
In group 1, 415 patients (83%) had phosphate levels below
0.60 mmol, as compared with 29 patients (8%) in group 2 (P
< 0.001). Moderate hypokalaemia (potassium <3.6 mmol/l)
was present in 170 patients (34%) in group 1 (despite
potassium supplementation and frequent measurements), as
compared with 20 patients (8%) in group 2 (P  < 0.001).
Severe hypokalaemia (potassium = 3.0 mmol/l) was present in
60 patients (12%) in group 1, as compared with eight patients
(3%) in group 2 (P < 0.01).
Overall, of patients in group 1, 438 (88%) had clinical defi-
ciency in at least one electrolyte, as compared with 50 (20%)
in group 2 (P < 0.001).
Discussion
Our findings clearly demonstrate that patients undergoing car-
diac surgical procedures with extracorporeal circulation are at
high risk for electrolyte depletion. This phenomenon occurred
despite the facts that our cardioplegia solution contained high
doses of potassium and magnesium, and that potassium sup-
plementation was given throughout the surgical procedure.
The mechanism for this appears to be a combination of
increased urinary excretion and intracellular shift, induced by a
combination of extracorporeal circulation and decreased body
temperature during surgery (hypothermia induced diuresis and
Table 2
Electrolyte levels at intensive care unit admission
Parameter Group 1 Group 2 P
Magnesium
Number of patients treated with magnesium before ICU admission 76% (n = 380) 2% (n = 5) P < 0.001
Magnesium levels (mmol/l) 0.62 ± 0.24 0.95 ± 0.27 P < 0.001
Magnesium levels in patients without magnesium supplementation during surgery 
(mmol/l)
0.47 ± 0.16 0.95 ± 0.26 P < 0.001
Patients with hypomagnesaemia 46% (n = 228) 16% (n = 40) P < 0.001
Patients with hypomagnesaemia in group with no magnesium supplementation 80% (n = 96) 1% (n = 3) P < 0.001
Phosphate
Phosphate levels (mmol/l) 0.43 ± 0.22 0.92 ± 0.32 P < 0.001
Patients with hypophosphataemia 83% (n = 415) 12% (n = 29) P < 0.001
Potassium
Potassium supplementation during surgery (mmol/hour) 10.1 ± 4.7 1.3 ± 1.0 P < 0.001
Potassium levels (mmol/l) 3.6 ± 0.70 3.9 ± 0.63 P < 0.01
Patients with hypokalaemia 34% (n = 170) 12% (n = 29) P < 0.001
Calcium
Calcium levelsa (mmol/l) 1.96 ± 0.41 2.12 ± 0.33 P < 0.01
Patients with hypocalcaemiaa 7.8% (n = 39) 5.6% (n = 15) P < 0.01
Sodium
Sodium levels (mmol/l) 134 ± 8 141 ± 9 P < 0.01
Patients with hyponatraemia 6% (n = 31) 5% (n = 12) NS
aCorrected to serum albumin levels of 4 g/dl. Where applicable, values expressed as mean ± standard error. ICU, intensive care unit; NS, not 
significant.Available online http://ccforum.com/content/8/6/R459
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intracellular shift). We previously reported induction of electro-
lyte depletion induced by hypothermia in patients with severe
head injury [32]; in these patients the responsible mechanism
was a combination of increased urinary loss and intracellular
shift. Indeed, high urinary excretion of magnesium, potassium
and phosphate was documented in our patients, although uri-
nary excretion alone could not account for our observations.
That urinary electrolyte excretion was high whereas serum
electrolyte levels were low indicates a degree of tubular dys-
function in our patients, despite the fact that serum creatinine
levels were normal; if tubular dysfunction were not present
then the kidney would have reabsorbed most of the excreted
electrolytes. The cause of the tubular dysfunction in our
patients is unknown. It seems likely that some of the medica-
tions used in their treatment played a role. All were treated with
low doses of dopamine, which can enhance renal excretion of
sodium and other electrolytes [34], and with catecholamines,
which can contribute significantly to the development of hypo-
phosphataemia [35]. About one-third of patients were given
diuretics before and/or during surgery; however, high electro-
lyte excretion also occurred in patients not given diuretics, and
so the effect cannot be explained by diuretics alone.
A potential limitation of the present study is that we did not
measure levels of ionized magnesium and ionized calcium in all
patients. However, we did measure ionized magnesium and
calcium in a subgroup of 40 patients in each group and found
similar differences; moreover, these differences were statisti-
cally significant. There is no reason to assume that protein
binding in the other patients was likely to be significantly differ-
ent between the two groups; in addition, albumin levels in
groups 1 and 2 were similar. We therefore feel that our obser-
vations of differences between the two subgroups are likely to
reflect real differences between the two groups overall.
A number of potential mechanisms could account for the intra-
cellular shifts that probably explain part of our findings. The
most common reason for electrolyte shifts is the occurrence of
changes in acid-base status (intracellular shift induced by alka-
losis). However, this did not occur in our patients because
acid-base status was regularly monitored and no major
changes were noted. However, a number of other metabolic
interactions might have taken place. For example, one of the
causes for intracellular shift of phosphate is an increase in
insulin levels. Although we did not measure insulin, a degree
of insulin resistance may have been induced in our patients fol-
lowing preoperative administration of corticosteroids. Another
reason may be loss of potassium and magnesium, each of
which can cause insulin resistance. The effects of extracorpor-
eal circulation are difficult to assess. Hypomagnesaemia in
patients undergoing open heart surgery was described in a
number of papers published about 30 years ago [36-39], and
attributed to haemodilution [38,39]. Urinary excretion of mag-
nesium or serum levels of other electrolytes were not meas-
ured in those studies; in retrospect, intraoperative hypothermia
might also have played a role in these observations. However,
it is not possible to separate the effects of extracorporeal cir-
culation from those of hypothermia either in those studies or in
the present one.
Remarkably, although the differences for cardiac surgery
patients were clear, low electrolyte levels (especially magne-
sium) were also observed quite frequently in control individu-
als. Of control individuals, 20% had at least one clinical
electrolyte deficiency (as compared with 88% in the study
group). Although our study was not designed to address this
issue, we strongly suspect that this phenomenon is related to
intraoperative hypothermia. Although all patients undergoing
cardiac surgery with extracorporeal circulation were intention-
ally cooled to approximately 32°C during surgery, mild acci-
dental hypothermia with body temperatures between 35°C
and 36°C occurred in many control patients during the
(lengthy) surgical procedures. We suspect that this might
have led to moderate electrolyte loss in these patients.
Low levels of magnesium, phosphate and, to a lesser degree,
calcium and potassium were observed despite the fact that all
patients were given substantial amounts of potassium during
surgery, and most patients received at least one bolus of mag-
nesium during the surgical procedure. A large number of these
patients met clinical criteria for hypomagnesaemia or hypo-
phosphataemia, or both; even hypokalaemia was found rela-
tively frequently, even though patients received considerable
potassium supplemention during the surgical procedure. This
latter observation might have been caused by the concomitant
presence of hypomagnesaemia, which can lead to significant
renal losses of potassium [12,13].
Low levels of magnesium cause not only cardiac arrhythmias
but also hypertension and vasoconstriction, including
constriction of coronary arteries [12,13,40-42]. Magnesium
appears to act as a physiological calcium channel blocking
agent, albeit without the associated negative inotropic effects
[40,43]. Moreover, the susceptibility of blood vessels (includ-
ing coronary arteries and presumably the mammarian arteries,
which are frequently used in bypass surgery) to vasoconstric-
tive agents is increased by hypomagnesaemia [42,44]. A
number of studies have documented low magnesium levels in
patients presenting with acute myocardial infarction [4-6] and
unstable angina [6,7]. Various animal experiments [45,46] and
clinical studies [8-11] have suggested that supplementing
magnesium in patients with unstable angina or suspected
myocardial infarction may prevent infarction or limit infarct size,
and reduce mortality. Although these observations do not
apply directly to patients undergoing open heart surgery, they
do indicate that hypomagnesaemia can be detrimental in situ-
ations in which coronary blood flow is threatened or impaired.
Another potentially important mechanism is the possible role
played by magnesium as a free radical scavenger in the pre-Critical Care    December 2004  Vol 8 No 6    Polderman and Girbes 
R464
vention of reperfusion injury [14,15], which may play a key role
in the development of postoperative complications in this cat-
egory of patients. Furthermore, a number of in vitro and animal
studies have shown that magnesium can prevent intracellular
sodium overload and excess mitochondrial calcium uptake
during ischaemic injury. These two developments are key ele-
ments in the progression of ischaemic injury to cell death, and
both are directly linked to the extent of ischaemic injury
[40,47,48]. A number of studies have reported decreases in
intraoperative and postoperative arrhythmias induced by addi-
tion of magnesium to warm blood cardioplegia or by intermit-
tent magnesium administration in patients undergoing
coronary artery bypass grafting [49-51].
In addition, magnesium may be linked to prevention of neuro-
logical injury after ischaemia or trauma [52,53]. Coronary
bypass surgery has been associated with transient or even
permanent neuropsychological deficits in up to 30% of
patients undergoing cardiac surgical procedures [54,55];
these injuries may be due to small thromotic emboli occurring
during surgery. Prevention of hypomagnesaemia may help to
mitigate these neurological injuries. All in all, there is a large
body of evidence suggesting that magnesium plays an impor-
tant role in preventing (additional) injury to the ischaemic or
injured heart, and perhaps also the brain. The effects of mag-
nesium depletion can be greatly enhanced in the presence of
other electrolyte disorders, especially hypokalaemia. Con-
versely, the effects of hypokalaemia may become manifest or
be enhanced in the presence of hypomagnesaemia; in addi-
tion, hypomagnesaemia can induce hypokalaemia through
increased renal potassium excretion, and hypokalaemia in turn
can cause hypomagnesaemia. These and other interactions of
potassium and magnesium are discussed more extensively in
various reviews [12,13]. As is the case for hypomagnesaemia,
hypokalaemia can induce cardiac arrhythmias (especially in
patients with ischemic heart disease and left ventricular hyper-
trophy). It is also associated with muscle weakness, rhab-
domyolysis, renal failure and hyperglycaemia.
Phosphate levels were low in the overall majority of cardiac
surgery patients we evaluated. The reasons why the depletion
of phosphate was more marked than for other electrolytes are
probably that phosphate was not supplemented during sur-
gery and perhaps that greater intracellular shift occurred due
to the mechanisms outlined above. Hypophosphataemia after
cardiac surgery was previously reported [56]; in the present
study hypophosphataemia was mitigated by blood transfu-
sions, because anticoagulant solutions used in stored blood
may contain relatively large amounts of phosphate. Various
adverse effects of hypophosphataemia on myocardial and res-
piratory function are described in the introduction section
above. On the basis of the studies cited, it appears plausible
that outcome in cardiac surgery may be adversely affected by
hypophosphataemia.
Clinical problems associated with hypocalcaemia are also
briefly outlined in the introduction section above. Mild hypoc-
alcaemia is frequently asymptomatic, although this depends
partly on the presence of other electrolyte disorders and on
the speed with which hypocalcaemia develops. Hypocalcae-
mia in our patients was generally mild, and might have been
caused in part by magnesium deficiency (which is a frequent
cause of hypocalcaemia). No visible symptoms of hypocalcae-
mia, such as tetany, were observed.
Arrhythmias occurred frequently in our cardiac surgery
patients, and antiarrhythmic medication (mostly amiodarone or
sotalol) was required in a substantial minority. It seems highly
likely that electrolyte disorders in our patients either caused
these arrhythmias or contributed to their development. Electro-
lytes were measured at ICU admission, and disorders were
corrected immediately; it seems highly likely that, if left
untreated, the disorders could have had a negative impact on
outcome.
Conclusion
We observed that patients undergoing cardiac surgery with
extracorporeal circulation are at high risk for electrolyte deple-
tion. The mechanism is probably a combination of increased
urinary excretion and intracellular shift, induced by a combina-
tion of intraoperative hypothermia and extracorporeal circula-
tion. Our findings may partly explain the high risk for
tachyarrhythmia in patients who have undergone cardiac sur-
gery. Alternatively, electrolyte depletion may increase the risk
for this complication. On the basis of our findings we recom-
mend that magnesium, potassium, phosphate and calcium be
frequently measured during and after cardiac surgery. Prophy-
lactic supplementation of potassium, magnesium and phos-
phate should be seriously considered in all cardiac surgery
patients during surgery and in the perioperative period.
Although mild hypocalcaemia usually does not require
treatment, it should be kept in mind that intravenous replace-
ment of phosphate and, to a lesser degree, magnesium can
aggravate existing hypocalcaemia (due to calcium binding to
phosphate, or to sulphate when MgSO4 is administered).
Therefore, if mild hypocalcaemia is present while high doses
of magnesium or phosphate are administered, calcium levels
should also be corrected. In our opinion, careful monitoring
and prompt correction of electrolytes will contribute to the pre-
vention of postoperative tachyarrhythmia and help to improve
outcomes in patients undergoing cardiac surgical procedures.Available online http://ccforum.com/content/8/6/R459
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